Pathway of PPAR-gamma coactivators in thermogenesis: A pivotal traditional Chinese medicine-associated target for individualized treatment of rheumatoid arthritis

Oncotarget

Volumn 7, Issue 13, 2016, Pages 15885-15900

  Zhang, Yanqiong ^a   Mao, Xia ^a   Guo, Qiuyan ^a   Bai, Ming ^b   Zhang, Bo ^b,c   Liu, Chunfang ^a   Sun, Yanqun ^a   Li, Shao ^b   Lin, Na ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b TSINGHUA UNIVERSITY   (China)

^c Tianjin International Joint Academy of Biotechnology and Medicine   (China)

Author keywords

Individualized treatment; Network pharmacology; PPAR gamma; Rheumatoid arthritis; Traditional chinese medicine syndrome

Indexed keywords

CHINESE DRUG; HERBACEOUS AGENT; NUCLEAR PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR; UNCLASSIFIED DRUG; WU TOU DECOCTION; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; WU-TOU;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHINESE MEDICINE; COLD SYNDROME; COLLAGEN-INDUCED ARTHRITIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; DRUG TARGETING; EXPERIMENTAL STUDY; FIBROBLAST; GENE TARGETING; HOT SYNDROME; HUMAN; HUMAN CELL; LOW DRUG DOSE; MALE; MATHEMATICAL COMPUTING; NONHUMAN; PERSONALIZED MEDICINE; PREDICTION; RAT; RHEUMATOID ARTHRITIS; SYNDROME; SYNOVIOCYTE; THERMOGENESIS; VALIDATION STUDY; AGONISTS; ANIMAL; DRUG EFFECTS; EXPERIMENTAL ARTHRITIS; GENE REGULATORY NETWORK; SPRAGUE DAWLEY RAT;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; DRUGS, CHINESE HERBAL; GENE REGULATORY NETWORKS; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; THERMOGENESIS;

EID: 84971622002     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.7419     Document Type: Article

References (47)

1. Lu AP, Jiang M, Zhang C, Chan K. An integrative approach of linking traditional Chinese medicine syndrome classification and biomedicine diagnosis. J Ethnopharmacol. 2012;141:549-56
2. Alraek T. Designing Clinical Studies That Take into Account Traditional East Asian Medicine's Systems and Methods-with Focus on Syndrome Identification. Chin J Integr Med. 2014; 20:332-5.
3. Li S. Advances in TCM symptomatology of rheumatoid arthritis. J Tradit Chin Med. 2002; 22:137-42.
4. He YT, Ou AH, Yang XB, Chen W, Fu LY, Lu AP, Yan XP, Feng XH, Su L, Song YJ, Zeng SP, Liu W, Qian X,et al. Traditional Chinese medicine versus western medicine as used in China in the management of rheumatoid arthritis: a randomized, single-blind, 24-week study. Rheumatol Int. 2014; 34:1647-55.
5. Que SW. The curative effect of rheumtoid arthritis by aconitum decoction. Clinical Journal of Chinese Medicine [In Chinese]. 2010; 2: 43-44.
6. Cao MQ, Cao Y. Clinical experiences of the application of modified wutou decoction that originated from the medical sage Zhang Zhongjin in the treatment of arthralgia syndrome observed in 120 cases. LiShiZhen Medicine and Materia Medica Research [In Chinese]. 2005; 16 : 896-7.
7. Wei SF, Li XL, Liang LN, Li LJ, Ma JL. Clinical observation of the combination of Duhuo Jisheng decoction and acupuncture and moxibustion in the treatment of rheumatoid arthritis in 40 cases. Guiding Journal of Traditional Chinese Medicine and Pharmacology [In Chinese]. 2012; 18: 67-8.
8. Xv YZ. Clinical observations of modified Duhuo Jisheng decoction in the treatment of rheumatoid arthritis. Chinese Journal of Medical Guide [In Chinese]. 2013; 15:1836-38.
9. Le WB, Li B. The combination of modified Guizhi Fuzi decoction and drugs for external use in the treatment of rheumatoid arthritis in 60 cases. Shaanxi Journal of Traditional Chinese Medicine [In Chinese]. 2011; 32: 985-6.
10. Lu QL. Discussions on the therapeutic efficacies and mechanisms of modified Guizhi Fuzi decoction and drugs for external use in the treatment of rheumatoid arthritis. China Practical Medical [In Chinese]. 2015; 10: 206-8.
11. Zhang WJ, Du XZ, Zhang ZZ, Huang JC. Clinical observation of the combination of Yiyiren decoction and thalidomide in the treatment of rheumatoid arthritis in 50 cases. Chinese Journal of Ethnomedicine and Ethnopharmacy [In Chinese]. 2013; 22: 44.
12. Jin J, An LP, Xiao MX. Analysis of efficacy of coixenolide soup for cold dampness closed-resistance of 35 cases of rheumatoid arthritis. Journal of Xinjiang Medical University [In Chinese]. 2008; 31: 591-3.
13. Chen SW. Curative effect observation of Tc-MDP combined with aconite decocotion in the treatment of rheumatoid arthritis. Chinese Journal of Medicinal Guide [In Chinese]. 2015; 17: 161-162.
14. Guo F, Zhen XM, Xie SH. Efficacy observation on treating 72 cases of RA in the integrative medicine. Clinical Journal of Chinese Medicine [In Chinese]. 2012; 4: 69-70.
15. Liu F, Fu HW, Wang JB, Wu HH, Yang L. Clinical observations of the combination of etanercept, leflunomide and wutou decoction in the treatment of rheumatoid arthritis. Hebei Medical Journal [In Chinese]. 2009; 31: 101-2.
16. Fu HW, Liu F, Xv HY. The combination of etanercept, leflunomide and wutou decoction in the treatment of rheumatoid arthritis. Hebei Medical Journal [In Chinese]. 2009; 31: 721-2.
17. Xiao Z. Clinical observation of modified Baihu Guizhi decoction in the treatment of rheumatoid arthritis in 32 case. Guiding Journal 0f Traditional Chinese Medicine and Pharmacology [In Chinese]. 2010; 16: 38-9.
18. Guo SX. Treatment of modified Baihu Guizhi decoction on rheumatoid arthritis in 120 cases. Modern Journal of Integrated Traditional Chinese and Western Medicine [In Chinese]. 2003; 12: 1163.
19. Wang RM, Jiu JL, Wang LZ. The combination of Bushen Juanbi decoction and western medicine in the treatment of rheumatoid arthritis in 200 cases. ShaanxiJournal of Traditional Chinese Medicine [In Chinese]. 2010; 31: 437-8.
20. Yuan SF. Clinical observation of Oral Danggui Niantong Decoction and Wuteng powder for 45 patients with rheumatoid arthritis of Moist Heat Arthralgia Spasm Syndrome. The Journal of Traditional Chinese Orthopedics and Traumatology [In Chinese]. 2011; 23: 20-3.
21. Chen XP, Li MY, Li J, Li CB. Treating 50 cases of blockage of rheumatoid arthritis hot and humid with Danggui Niantong decoction. Clinical Journal of Chinese Medicine [In Chinese]. 2010; 2: 78.
22. Yang M, Xiao CH, Wu QF, Chen DC, Huang SF. Clinical observations of Sanshui Baihu decoction in the treatment of active rheumatoid arthritis in 59 cases. New Journal of Traditional Chinese Medicine [In Chinese]. 2006; 38: 52-4.
23. Zhang CQ, Zhen M, Zhang WN. Clinical observation of Tongluo Juanbi decoction in the treatment of rheumatoid arthritis characterized with hot dampness closed-resistance in 30 cases. Chinese Journal of Information on Traditional Chinese Medicine [In Chinese]. 2009; 16: 65-6.
24. Li S, Zhang ZQ, Wu LJ, Zhang XG, Li YD, Wang YY. Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. IET Syst Biol. 2007; 1: 51-60.
25. Li R, Ma T, Gu J, Liang X, Li S. Imbalanced network biomarkers for traditional Chinese medicine Syndrome in gastritis patients. Sci Rep. 2013; 3: 1543.
26. Hatazawa Y, Tadaishi M, Nagaike Y, Morita A, Ogawa Y, Ezaki O, Takai-Igarashi T, Kitaura Y, Shimomura Y, Kamei Y, Miura S. PGC-1α-mediated branched-chain amino acid metabolism in the skeletal muscle. PLoS One. 2014; 9: e91006.
27. Russell AP. PGC-1alpha and exercise: important partners in combating insulin resistance. Curr Diabetes Rev. 2005; 1: 175-81.
28. Shahin D, Toraby EE, Abdel-Malek H, Boshra V, Elsamanoudy AZ, Shaheen D. Effect of peroxisome proliferator-activated receptor gamma agonist (pioglitazone) and methotrexate on disease activity in rheumatoid arthritis (experimental and clinical study). Clin Med Insights Arthritis Musculoskelet Disord. 2011; 4: 1-10.
29. Marder W, Khalatbari S, Myles JD, Hench R, Lustig S, Yalavarthi S, Parameswaran A, Brook RD, Kaplan MJ. The peroxisome proliferator activated receptor-γ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis. J Am Heart Assoc. 2013; 2: e000441.
30. Lv S, Wang Q, Li G, Sun S, Guo Y, Kuang H. The treatment of rheumatoid arthritis using Chinese medicinal plants: From pharmacology to potential molecular mechanisms. J Ethnopharmacol. 2015; 176: 177-206.
31. Zhang YQ, Bai M, Zhang B, Liu CF, Guo QY, Sun YQ, Wang DH, Wang C, Jiang YN, Lin N, Li S. Uncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: drug-target prediction, network analysis and experimental validation. Sci Rep. 2015; 5: 9463.
32. Zhang Y, Wang D, Tan S, Xu H, Liu C, Lin N. A systems biology-based investigation into the pharmacological mechanisms of wu tou tang acting on rheumatoid arthritis by integrating network analysis. Evid Based Complement Alternat Med. 2013; 2013: 548498.
33. Li S. Mapping ancient remedies: Applying a network approach to traditional Chinese medicine. Science 2015; 350: S72-S74.
34. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003; 4: P3.
35. Zhao S, Li S. Network-based relating pharmacological and genomic spaces for drug target identification. PLoS One. 2010; 5: e11764.
36. Ye XX, Wen GK. Analysis on the therapeutic effects of the combination of wutou decoction and physiotherapy in the treatment of arthralgia due to wind-cold dampness. 2014; 30: 119-120.
37. Li GS. The analysis of the formala principle and clinical application of Guizhi shaoyao zhimu decoction and wutou decoction. Journal of Traditional Chinese Medicinal Literature. 2008; 26: 23-4.
38. Qi Y, Li S, Pi Z, Song F, Lin N, Liu S, Liu Z. Metabonomic study of Wu-tou decoction in adjuvant-induced arthritis rat using ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2014; 953-954: 11-9.
39. Caudarella R, Vescini F, Buffa A, Stefoni S. Citrate and mineral metabolism: kidney stones and bone disease. Front Biosci. 2003; 8: s1084-106.
40. Koufany M, Jouzeau JY, Moulin D. Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis. Biomed Mater Eng. 2014; 24: 81-8.
41. Ormseth MJ, Oeser AM, Cunningham A, Bian A, Shintani A, Solus J, Tanner SB, Stein CM. Reversing vascular dysfunction in rheumatoid arthritis: improved augmentation index but not endothelial function with peroxisome proliferator-activated receptor γ agonist therapy. Arthritis Rheumatol. 2014; 66: 2331-8.
42. Yamasaki S, Nakashima T, Kawakami A, Miyashita T, Tanaka F, Ida H, Migita K, Origuchi T, Eguchi K. Cytokines regulate fibroblast-like synovial cell differentiation to adipocyte-like cells. Rheumatology (Oxford). 2004; 43: 448-52.
43. Kokkonen H, Mullazehi M, Berglin E, Hallmans G, Wadell G, Rönnelid J, Rantapää-Dahlqvist S. Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis. Arthritis Res Ther. 2011; 13: R13.
44. Zhang Y, Guo X, Wang D, Li R, Li X, Xu Y, Liu Z, Song Z, Lin Y, Li Z, Lin N. A systems biology-based investigation into the therapeutic effects of Gansui Banxia Tang on reversing the imbalanced network of hepatocellular carcinoma. Sci Rep. 2014; 4: 4154.
45. Kong X, Zhang Y, Liu C, Guo W, Li X, Su X, Wan H, Sun Y, Lin N. Anti-angiogenic effect of triptolide in rheumatoid arthritis by targeting angiogenic cascade. PLoS One. 2013; 8.
46. Liu C, Zhang Y, Kong X, Zhu L, Pang J, Xu Y, Chen W, Zhan H, Lu A, Lin N. Triptolide Prevents Bone Destruction in the Collagen-Induced Arthritis Model of Rheumatoid Arthritis by Targeting RANKL/RANK/OPG Signal Pathway. Evid Based Complement Alternat Med. 2013; 2013: 626038.
47. Lin N, Liu C, Xiao C, Jia H, Imada K, Wu H, Ito A. Triptolide, a diterpenoid triepoxide, suppresses inflammation and cartilage destruction in collagen-induced arthritis mice. Biochem Pharmacol. 2007; 73: 136-46.